Table 2.
Associations between SOX6, GAGE and MAGE-E1 expression and clinical characteristics in patients with glioblastoma
| P-value | Tumor location |
P-value | Gender | Cancer/Testis Antigens | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Female | Male | |||||||||
| Other | Occipital | Parietal | Temporal | Frontal | ||||||
| 0.380 | 6 | 1 | 6 | 7 | 10 | 0.490 | 13 | 17 | 2+/3+ | SOX6 expression |
| 1 | 3 | 2 | 6 | 8 | 10 | 10 | -/1+ | |||
| 0.203 | 3 | 2 | 0 | 3 | 4 | 0.305 | 3 | 9 | 2+/3+ | GAGE expression |
| 4 | 2 | 8 | 10 | 14 | 20 | 18 | -/1+ | |||
| 0.893 | 6 | 2 | 4 | 10 | 13 | 0.288 | 13 | 22 | 2+/3+ | MAGE-E1 expression |
| 1 | 2 | 4 | 3 | 5 | 10 | 5 | -/1+ | |||